Physician profile
Steven Kim
NPI 1356574099
$964.40
in general payments reported to CMS, 2019-2025
12 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.20 · 2022: $105 · 2023: $173 · 2024: $382 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $264.47 | 2024-2025 | Eterna |
| Merck Sharp & Dohme LLC | $179.51 | 2022-2024 | Verquvo |
| Atricure, INC. | $155.45 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $108.50 | 2022-2023 | |
| Boston Scientific Corporation | $67.50 | 2023-2025 | Varithena Administration Pack |
| Astellas Pharma US INC | $36.66 | 2025 | Xtandi |
| Kiniksa Pharmaceuticals International, Plc | $34.63 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $32.11 | 2024 | Inspire |
| Angiodynamics, INC. | $23.37 | 2025 | Bioflo |
| Biocompatibles, INC. | $23.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.00 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.